Sleep and Metabolism in Obesity: Impact of Gender
Sleep and Metabolism in Obesity: Impact of Gender
批准号:
7334638
负责人:
DAVID A EHRMANN
金额:
$25.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2012-08-31
关键词:
AccountingAddressAdipocytesAdrenal Gland HyperfunctionAdultAdverse effectsAffectAftercareAgeAgingAmericanBeta CellBiopsyBlood PressureBody fatBrainC-reactive proteinCardiacCardiovascular systemCatecholaminesCharacteristicsChronicClinicalCommunitiesConditionContinuous Positive Airway PressureCushing SyndromeDataData SetDepthDevelopmentDiagnosticDiseaseDyslipidemiasElectroencephalographyElevationEnrollmentEquilibriumFatty acid glycerol estersFrequenciesFunctional disorderGenderGlucocorticoidsGlucoseGoalsGonadal Steroid HormonesHealthHealthcareHepaticHydrocortisoneHypertensionHypoxiaIndividualIndividual DifferencesInflammatoryInpatientsInsulin ResistanceInterdisciplinary StudyLeadLinkLipidsMagnetic Resonance ImagingMeasuresMental DepressionMetabolicMetabolic syndromeMetabolismNon obeseNumbersObesityObstructive Sleep ApneaOutcomeOutputOverweightPituitary-Adrenal SystemPlasmaPlayPolysomnographyPremenopausePrevalencePreventionPrincipal InvestigatorProceduresProtocols documentationREM SleepRangeRecurrenceRegulationRisk FactorsRoleScreening procedureSex CharacteristicsSleepSleep Apnea SyndromesSleep FragmentationsSleep StagesSleep disturbancesSleeplessnessSlow-Wave SleepSomatotropinStudy SubjectTestingTherapeuticTimeTodayTriglyceridesWomanWorkadipokinesbasecardiovascular risk factorcytokinedaydiabetes riskglucose toleranceimprovedindexinginsightinsulin sensitivityintravenous glucose tolerance testmennon rapid eye movementnon-diabeticprogramsrespiratorysexsleep regulationsubcutaneoustrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Obesity is a major risk factor for obstructive sleep apnea (OSA), a condition characterized by repetitive
respiratory disturbances, intermittent hypoxia, sleep fragmentation by frequent microarousals and low
amounts of deep slow wave sleep [SWS]). Today, more than 10 million American women suffer from OSA.
OSA has been identified as an independent risk factor for the metabolic syndrome. Because OSA is more
prevalent in men than in women, a disproportionate number of studies of OSA and its consequences have
been conducted in men. Thus, OSA has been characterized as a disorder associated with gender-based
health care inequity. Recent evidence, including data from our group, suggests that reduced amounts and
intensity of SWS (i.e.slow-wave activity [SWA]) may play a pivotal role in the development of metabolic and
cardiovascular disturbances in obese men and women, particularly those with OSA. The present project will
focus on sex differences in SWA and their relationship with daytime sleepiness and metabolic vulnerability in
obese men and women with and without OSA. We propose to simultaneously characterize: 1. sleep-wake
regulation; 2. measures of diabetes risk 3. measures of cardiovascular risk and 4. profiles of sex steroids,
cortisol and adipokines in a. obese men without OSA, b. obese men with OSA before and after treatment
with continuous positive airway pressure (CPAP), c. obese pre-menopausal women without OSA, and d.
obese pre-menopausal women with OSA before and after CPAP treatment. The completion of these
interdisciplinary studies will provide a unique data set contrasting in obese women versus obese men the
relationships between sleep and the metabolic syndrome, OSA and the metabolic syndrome and the impact
of CPAP treatment on the metabolic syndrome. The proposed work will provide important insights regarding
the pathophysiology of OSA and its adverse consequences in obese men and women, and the basis for the
development of effective sex-specific prevention and treatment strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8864376
-
项目类别:
-
资助金额:$26.07万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women
-
批准号:8326136
-
项目类别:
-
资助金额:$34.85万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8247929
-
项目类别:
-
资助金额:$70.97万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8698745
-
项目类别:
-
资助金额:$63.03万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8669442
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8535748
-
项目类别:
-
资助金额:$54.23万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8335414
-
项目类别:
-
资助金额:$60.7万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Enhancement of Beta Cell Function with Pharmacologic and Sleep Apnea Treatment
-
批准号:8530646
-
项目类别:
-
资助金额:$55.12万
-
财政年份:2011
-
负责人:DAVID A EHRMANN
-
依托单位:
Administrative Core
-
批准号:7334637
-
项目类别:
-
资助金额:$17.14万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7678045
-
项目类别:
-
资助金额:$119.14万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7928876
-
项目类别:
-
资助金额:$121.03万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Assessment of Adipocyte Function in Women with PCOS
-
批准号:7334641
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
GENETICS OF PCOS
-
批准号:7604742
-
项目类别:
-
资助金额:$0.76万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, Body Fat, and Plasma Triglycerides in Women
-
批准号:7334640
-
项目类别:
-
资助金额:$28.49万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
PCOS, Sleep Apnea, and Metabolic Risk in Women
-
批准号:7334639
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7504105
-
项目类别:
-
资助金额:$115.82万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:7288418
-
项目类别:
-
资助金额:$116.19万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
Sex steroids, Sleep, and Metabolic Dysfunction in Women
-
批准号:8134784
-
项目类别:
-
资助金额:$119.38万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
SLEEP AND PCOS
-
批准号:7604763
-
项目类别:
-
资助金额:$7.66万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
PIOGLITAZONE & ETHINYL ESTRADIOL/DROSPERINONE IN THE TREATMENT OF PCOS
-
批准号:7604775
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2007
-
负责人:DAVID A EHRMANN
-
依托单位:
海外基金